Top compounds associated with response to ERMARD


Feature Type Standardized
Nominal ANOVA
mRNA Imatinib CTRPv2 pan-cancer AAC 0.12 0.001
mRNA NG-25 GDSC1000 pan-cancer AAC 0.095 0.002
mRNA Genentech Cpd 10 GDSC1000 pan-cancer AAC 0.097 0.003
mRNA BIX02189 GDSC1000 pan-cancer AAC 0.098 0.003
mRNA regorafenib CTRPv2 pan-cancer AAC 0.11 0.003
mRNA Tamoxifen GDSC1000 pan-cancer AAC 0.1 0.003
mRNA SRT-1720 CTRPv2 pan-cancer AAC 0.11 0.003
mRNA Tipifarnib GDSC1000 pan-cancer AAC 0.11 0.004
mRNA Vinorelbine GDSC1000 pan-cancer AAC 0.1 0.004
mRNA GSK2126458 GDSC1000 pan-cancer AAC 0.093 0.004
Download CSV